Vbi Vaccines Inc – Ordinary Shares (NASDAQ:VBIV) Sellers Rose Their Shorts By 11.31% As Of Jun 27, 2018

June 27, 2018 - By Andre Harris

VBI Vaccines Inc. (NASDAQ:VBIV) Corporate Logo

It was showed an increase on Vbi Vaccines Inc – Ordinary Shares (NASDAQ:VBIV)’s shorted shares with 11.31%. FINRA announced shorted shares of VBIV’s total 820,900 shares. That’s 11.31% up from 737,500 shares. 6 days will cost VBIV with 131,400 average volume to restore its former position. Vbi Vaccines Inc – Ordinary Shares’s shorted shares float is 2.14%.

Ticker’s shares touched $2.85 during the last trading session after 2.73% change.VBI Vaccines Inc. has volume of 105,434 shares. Since June 27, 2017 VBIV has declined 26.86% and is downtrending. VBIV underperformed the S&P 500 by 39.43%.

VBI Vaccines Inc., a commercial stage biopharmaceutical company, develops vaccines to address unmet needs in infectious disease and immuno-oncology in Israel and internationally.The company has $183.02 million market cap. It is developing eVLP, a vaccine platform for the design of enveloped virus-like particle vaccines; and Lipid Particle Vaccine technology, a vaccine formulation technology that enables the thermostabilization of vaccines through a proprietary formulation and freeze-drying process.Last it reported negative earnings. The firm also offers Sci-B-Vac, a third-generation hepatitis B vaccine for adults, children, and newborn infants.

There’s an important VBI Vaccines Inc. (NASDAQ:VBIV) news released by Globenewswire.com. It’s an item titled: “VBI Vaccines to Present at 2018 JMP Securities Life Sciences Conference” on June 19, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: